The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
Abstract
MicroRNAs have been implicated in regulating diverse cellular pathways. Although there is emerging evidence that some microRNAs can function as oncogenes or tumour suppressors, the role of microRNAs in mediating cancer metastasis remains unexplored. Here we show, using a combination of mouse and human cells, that microRNA-10b (miR-10b) is highly expressed in metastatic breast cancer cells and positively regulates cell migration and invasion. Overexpression of miR-10b in otherwise non-metastatic breast tumours initiates robust invasion and metastasis. Expression of miR-10b is induced by the transcription factor Twist, which binds directly to the putative promoter of mir-10b (MIRN10B). The miR-10b induced by Twist proceeds to inhibit translation of the messenger RNA encoding homeobox D10, resulting in increased expression of a well-characterized pro-metastatic gene, RHOC. Significantly, the level of miR-10b expression in primary breast carcinomas correlates with clinical progression. These findings suggest the workings of an undescribed regulatory pathway, in which a pleiotropic transcription factor induces expression of a specific microRNA, which suppresses its direct target and in turn activates another pro-metastatic gene, leading to tumour cell invasion and metastasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This expression pattern is different from those of the other cancer-associated miRNAs, for example, miR-10b, which is often elevated in grade III and even grade II gliomas (Fig. 1) and dysregulated in some other cancers (41).”
From MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators (2008) · cites this paper as [41]
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
MicroRNA expression profiles classify human cancers
Lü, J., Getz, G. A., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,637
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1997 · Cited by 7,668
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature reviews. Cancer · doi:10.1038/nrc822 · Cited by 6,767
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
Prediction of Mammalian MicroRNA Targets
Lewis, B. P., Shih, I.-H., Jones-Rhoades, M. W., Bartel, D. P., & Burge, C. B. (2003) · Cell · doi:10.1016/s0092-8674(03)01018-3 · Cited by 5,199
The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited
Fidler, I. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1098 · Cited by 4,686
Combinatorial microRNA target predictions
Krek, A., Grün, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I., Gunsalus, K. C., Stoffel, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1536 · Cited by 4,603
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,096
MicroRNA Gene Expression Deregulation in Human Breast Cancer
Iorio, M. V., Ferracin, M., Liu, C.-G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1783 · Cited by 4,053
Cited by
Sorted by citations
Items 701–800 of 1,004
Hassel, D., Cheng, P. P., White, M. P., Ivey, K. N., Krøll, J., Augustin, H. G., Katus, H. A., Stainier, D. Y. R., & Srivastava, D. (2012) · Circulation Research · doi:10.1161/circresaha.112.279711 · Cited by 86
Zheng, L., Pu, J., Qi, T., Meng, Q., Li, D., Xiang, X., Huang, K., & Tong, Q. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0534 · Cited by 86
Lei, B., Wang, D., Zhang, M., Deng, Y., Jiang, H., & Li, Y. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01571-5 · Cited by 85
Wee, E. J. H., Peters, K. M., Nair, S. S., Hulf, T., Stein, S. R., Wagner, S., Bailey, P. J., Lee, S., Qu, W. J., Brewster, B. L., et al. (2012) · Oncogene · doi:10.1038/onc.2011.584 · Cited by 87
MicroRNA-661, a c/EBPα Target, Inhibits Metastatic Tumor Antigen 1 and Regulates Its Functions
Reddy, S. D. N., Pakala, S. B., Ohshiro, K., Rayala, S. K., & Kumar, R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0898 · Cited by 85
miR-320a suppresses colorectal cancer progression by targeting Rac1
Zhao, H., Dong, T., Zhou, H., Wang, L., Huang, A., Feng, B., Quan, Y., Jin, R., Zhang, W., Sun, J., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt378 · Cited by 86
DLC1: a significant GAP in the cancer genomePreprint
Lahoz, A., & Hall, A. (2008) · Genes & Development · doi:10.1101/gad.1691408 · Cited by 86
Serum Overexpression of MicroRNA-10b in Patients with Bone Metastatic Primary Breast Cancer
Zhao, F.-L., Hu, G.-D., Wang, X., Zhang, X.-H., Zhang, Y.-K., & Yu, Z.-S. (2012) · Journal of International Medical Research · doi:10.1177/147323001204000304 · Cited by 85
MicroRNAs in colorectal cancer: Small molecules with big functions
Yu, X., Yang, H., Zhao, L., Lau, W. B., Lau, B., Ren, N., Hu, Y., Yi, T., Zhao, X., Zhou, S., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.11.051 · Cited by 84
Tong, J. L., Zhang, C. P., Nie, F., Xi Tao, X. U., Zhu, M., Shu Dong, X. I. A. O., & Ran, Z. H. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.10.021 · Cited by 84
MiR-9 and miR-21 as prognostic biomarkers for recurrence in papillary thyroid cancer
Sondermann, A., Andreghetto, F. M., Moulatlet, A. C. B., Victor, E. D. S., de Castro, M. G., Nunes, F. D., Brandão, L. G., & Severino, P. (2015) · Clinical & Experimental Metastasis · doi:10.1007/s10585-015-9724-3 · Cited by 84
Lin, H.-Y., Chiang, C.-H., & Hung, W. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.349 · Cited by 78
MicroRNAs in diseases and drug response
Garofalo, M., Condorelli, G., & Croce, C. M. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.06.005 · Cited by 85
Critical analysis of the potential for microRNA biomarkers in breast cancer management
Sempere, L. F., Graveel, C. R., Calderone, H. M., Westerhuis, J. J., & Winn, M. E. (2015) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s43799 · Cited by 84
Zhu, Q., Gong, L., Wang, J., Tu, Q., Li, Y., Zhang, J.-R., Han, X., Zhu, S., Wang, S., Li, Y., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2801-4 · Cited by 84
The role of oncomirs in the pathogenesis and treatment of breast cancer
Hemmatzadeh, M., Mohammadi, H., Jadidi‐Niaragh, F., Asghari, F., & Yousefi, M. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.01.026 · Cited by 85
MicroRNAs in cancer treatment and prognosis.
Schoof, C. R. G., Botelho, E. L. D. S., Izzotti, A., & Vasques, L. R. (2012) · Europe PMC (PubMed Central) · Cited by 82
Fortunato, O., Boeri, M., Moro, M., Verri, C., Mensah, M., Conte, D., Caleca, L., Roz, L., Pastorino, U., & Sozzi, G. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.507 · Cited by 83
Hugo, H. J., Kokkinos, M. I., Blick, T., Ackland, M. L., Thompson, E. W., & Newgreen, D. F. (2010) · Cells Tissues Organs · doi:10.1159/000320174 · Cited by 88
microRNAs and lung cancer: tumors and 22-mers
Du, L., & Pertsemlidis, A. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9204-9 · Cited by 81
MicroRNAs in clinical oncology: at the crossroads between promises and problems
Metias, S., Lianidou, E. S., & Yousef, G. M. (2009) · Journal of Clinical Pathology · doi:10.1136/jcp.2009.064717 · Cited by 83
The Inflammatory Tumor Microenvironment, Epithelial Mesenchymal Transition and Lung Carcinogenesis
Heinrich, E. L., Walser, T. C., Krysan, K., Liclican, E. L., Grant, J. L., Rodriguez, N., & Dubinett, S. M. (2011) · Cancer Microenvironment · doi:10.1007/s12307-011-0089-0 · Cited by 87
Da, C.-L., Liu, Y., Zhan, Y., Liu, K., & Wang, R. (2016) · Oncology Reports · doi:10.3892/or.2016.4661 · Cited by 84
Non-Coding RNAs as Regulators of Mammary Development and Breast Cancer
Piao, H.-L., & Ma, L. (2012) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-012-9245-5 · Cited by 81
Self-citationMulrane, L., Madden, S. F., Brennan, D. J., Gremel, G., McGee, S. F., McNally, S., Martin, F., Crown, J. P., Jirström, K., Higgins, D. G., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1420 · Cited by 82
Li, Q., Zhu, F., & Chen, P. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.06.028 · Cited by 82
MicroRNAs and Cancer: A Long Story for Short RNAs
Drusco, A., & Croce, C. M. (2017) · Advances in cancer research · doi:10.1016/bs.acr.2017.06.005 · Cited by 83
Zhang, L., Chen, X., & Yin, J. (2019) · Cells · doi:10.3390/cells8091040 · Cited by 82
Mechanistic Pathways of Malignancy in Breast Cancer Stem Cells
Yousefnia, S., Forootan, F. S., Forootan, S. S., Nasr‐Esfahani, M. H., Gure, A. O., & Ghaedi, K. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00452 · Cited by 82
Expression profiling of microRNA using oligo DNA arrays
Liu, C.-G., Spizzo, R., Calin, G. A., & Croce, C. M. (2008) · Methods · doi:10.1016/j.ymeth.2007.10.010 · Cited by 84
Wang, D., Huang, J., & Hu, Z. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.011932 · Cited by 85
Genomic characterization of liver metastases from colorectal cancer patients
Sayagués, J. M., Corchete, L. A., Gutiérrez, M. L., Sarasquete, M. E., Abad, M., Bengoechea, Ó., Fermiñán, E., Anduaga, M. F., del Carmen, S., Iglesias, M. J. I., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12140 · Cited by 84
Hou, X., Tang, Z., Liu, H., Wang, N., Ju, H., & Li, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052123 · Cited by 81
Kahlert, C., Klupp, F., Brand, K., Lasitschka, F., Diederichs, S., Kirchberg, J., Rahbari, N. N., Dutta, S., Bork, U., Fritzmann, J., et al. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02023.x · Cited by 81
MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer
Stiegelbauer, V. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i33.11727 · Cited by 83
Bourguignon, L., Earle, C., & Shiina, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091849 · Cited by 81
Feng, X., Luo, Q., Wang, H., Zhang, H., & Chen, F. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26331 · Cited by 83
Cantini, L., Bertoli, G. R., Cava, C., Dubois, T., Zinovyev, A. Y., Caselle, M., Castiglioni, I., Barillot, E., & Martignetti, L. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz016 · Cited by 84
Xiao, W., Wang, X., Wang, T., & Xing, J. (2019) · Aging · doi:10.18632/aging.101763 · Cited by 81
Prediction of Potential Disease-Associated MicroRNAs by Using Neural Networks
Zeng, X., Wang, W., Deng, G., Bing, J., & Zou, Q. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.04.010 · Cited by 78
Ahmad, A., Ginnebaugh, K. R., Yin, S., Bollig-Fischer, A. B., Reddy, K. B., & Sarkar, F. H. (2015) · BMC Cancer · doi:10.1186/s12885-015-1561-x · Cited by 81
Sulindac inhibits tumor cell invasion by suppressing NF-κB-mediated transcription of microRNAs
Li, X., Gao, L., Cui, Q., Gary, B. D., Dyess, D. L., Taylor, W., Shevde, L. A., Samant, R. S., Dean-Colomb, W. M., Piazza, G. A., et al. (2012) · Oncogene · doi:10.1038/onc.2011.655 · Cited by 81
Mechanical factors activateß‐catenin‐dependent oncogene expression in APC1638N/+mouse colon
Whitehead, J., Vignjevic, D. M., Fütterer, C., Beaurepaire, E., Robine, S., & Farge, E. (2008) · HFSP journal · doi:10.2976/1.2955566 · Cited by 93
MicroRNAs and Metastasis-related Gene Expression in Egyptian Breast Cancer Patients
Hafez, M. M., Hassan, Z. K., Zekri, A. N., Gaber, A. A., Rejaie, S. S. A., Sayed‐Ahmed, M. M., & Shabanah, O. A. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.2.591 · Cited by 82
microRNAs in Gliomas: Small Regulators of a Big Problem
Silber, J., James, C. D., & Hodgson, J. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8087-9 · Cited by 80
Zhai, H., Fesler, A. T., & Ju, J. (2013) · Cell Cycle · doi:10.4161/cc.23273 · Cited by 82
Severino, P., Brüggemann, H., Andreghetto, F. M., Camps, C., Klingbeil, M. F. G., Pereira, W. O., Soares, R. M., Moysés, R. A., Wünsch‐Filho, V., Mathor, M. B., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-533 · Cited by 80
Using Genome Sequence to Enable the Design of Medicines and Chemical Probes
Angelbello, A. J., Chen, J. L., Childs‐Disney, J. L., Zhang, P., Wang, Z.-F., & Disney, M. D. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00504 · Cited by 81
Non-coding RNAs as potential therapeutic targets in breast cancer
Tomar, D., Yadav, A. S., Kumar, D., Bhadauriya, G., & Kundu, G. C. (2019) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2019.04.005 · Cited by 82
MicroRNAs and Triple Negative Breast Cancer
D’Ippolito, E., & Iorio, M. V. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141122202 · Cited by 83
miRNAs can be generally associated with human pathologies as exemplified for miR-144*
Keller, A., Leidinger, P., Vogel, B., Backes, C., ElSharawy, A., Galata, V., Mueller, S. C., Marquart, S., Schrauder, M. G., Strick, R., et al. (2014) · BMC Medicine · doi:10.1186/s12916-014-0224-0 · Cited by 80
Srivastava, S. K., Arora, S., Averett, C., Singh, S., & Singh, A. P. (2015) · BioMed Research International · doi:10.1155/2015/848710 · Cited by 84
MicroRNAs as Biomarkers in Colorectal Cancer
Schee, K., Fodstad, Ø., & Flatmark, K. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100024 · Cited by 80
Rho GTPases: Big Players in Breast Cancer Initiation, Metastasis and Therapeutic Responses
Humphries, B. A., Wang, Z., & Yang, C. (2020) · Cells · doi:10.3390/cells9102167 · Cited by 78
miR-206 inhibits metastasis-relevant traits by degrading MRTF-A in anaplastic thyroid cancer
ZHANG, W.-L., LV, W., SUN, S.-Z., WU, X.-Z., & ZHANG, J.-H. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2993 · Cited by 75
Mardente, S., Mari, E., Consorti, F., Gioia, C. R. T. D., Negri, R., Etna, M. P., Zicari, A., & Antonaci, A. (2012) · Oncology Reports · doi:10.3892/or.2012.2058 · Cited by 79
The microRNA-200 Family Regulates Epithelial to Mesenchymal Transition
Paterson, E. L., Kolesnikoff, N., Gregory, P. A., Bert, A. G., Khew‐Goodall, Y., & Goodall, G. J. (2008) · The Scientific World JOURNAL · doi:10.1100/tsw.2008.115 · Cited by 80
Paz, S., Ritchie, A., Mauer, C., & Caputi, M. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.10.008 · Cited by 77
TWIST1 Expression in Breast Cancer Cells Facilitates Bone Metastasis Formation
Croset, M., Goehrig, D., Frackowiak, A., Bonnelye, E., Ansieau, S., Puisieux, A., & Clézardin, P. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2215 · Cited by 78
Heparin Impairs Angiogenesis through Inhibition of MicroRNA-10b
Shen, X., Fang, J., Lv, X., Pei, Z., Wang, Y., Jiang, S., & Ding, K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.224212 · Cited by 78
Dou, T., Wu, Q., Chen, X., Ribas, J., Ni, X., Tang, C., Huang, F., Zhou, L., & Lu, D. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0844-5 · Cited by 78
MicroRNA prediction with a novel ranking algorithm based on random walks
Xu, Y., Zhou, X., & Zhang, W. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn175 · Cited by 78
Epigenetically Reprogramming Metastatic Tumor Cells With An Embryonic Microenvironment
Costa, F. F., Seftor, E. A., Bischof, J. M., Kirschmann, D. A., Strizzi, L., Arndt, K., Bonaldo, M. F., Soares, M. B., & Hendrix, M. J. C. (2009) · Epigenomics · doi:10.2217/epi.09.25 · Cited by 82
Non-coding RNAs: Identification of Cancer-Associated microRNAs by Gene Profiling
Ferdin, J., Kunej, T., & Calin, G. A. (2010) · Technology in Cancer Research & Treatment · doi:10.1177/153303461000900202 · Cited by 79
Zhang, Q., Ran, R., Zhang, L., Liu, Y., Mei, L., Zhang, Z., Gao, H., & He, Q. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.11.010 · Cited by 77
MicroRNAs in breast cancer initiation and progression
Liu, H. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1128-9 · Cited by 85
STARD13-correlated ceRNA network inhibits EMT and metastasis of breast cancer
Li, X., Zheng, L., Zhang, F., Hu, J., Chou, J., Liu, Y., Xing, Y., & Xi, T. (2016) · Oncotarget · doi:10.18632/oncotarget.8099 · Cited by 77
Kim, H., Choi, P., Kim, T., Kim, Y.-S., Song, B. G., Park, Y., Choi, S.-J., Yoon, C. H., Lim, W., Ko, H., et al. (2020) · Journal of Ginseng Research · doi:10.1016/j.jgr.2020.02.005 · Cited by 77
Kunz, M. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-5590-1_6 · Cited by 86
MicroRNA‐224 is upregulated in HepG2 cells and involved in cellular migration and invasion
Li, Q., Wang, G., Shan, J., Yang, Z., Wang, H., Feng, J., Zhen, J., Chen, C., Zhang, Z., Xu, W., et al. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05971.x · Cited by 78
Nairismägi, M., Vislovukh, A. A., Meng, Q., Kratassiouk, G., Beldiman, C., Petretich, M., Groisman, R., Füchtbauer, E.-M., Harel‐Bellan, A., & Groisman, I. (2012) · Oncogene · doi:10.1038/onc.2011.650 · Cited by 81
Epigenetic Regulation of Cancer-Associated Genes in Ovarian Cancer
Kwon, M. J., & Shin, Y. K. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12020983 · Cited by 79
Wang, Q., Huang, Z., Guo, W., Ni, S., Xiao, X., Wang, L., Huang, D., Tan, C., Xu, Q., Zha, R., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1023 · Cited by 77
Ding, Y., Zhang, C., Zhang, J., Zhang, N., Li, T., Fang, J., Zhang, Y., Zuo, F., Tao, Z., Tang, S., et al. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.3945 · Cited by 77
MicroRNA-34a suppresses colorectal cancer metastasis by regulating Notch signaling
Zhang, X., Ai, F., Li, X., Li, T. X., Wang, X., Shen, S., & Liu, F. (2017) · Oncology Letters · doi:10.3892/ol.2017.6444 · Cited by 78
Mantle cell lymphoma: transcriptional regulation by microRNAs
Lisio, L. D., Goméz-López, G., Sánchez‐Beato, M., Gomez-Abad, C. I., Rodríguez, M. E., Villuendas, R., Ferreira, B. I., Carro, Á., Rico, D., Mollejo, M., et al. (2010) · Leukemia · doi:10.1038/leu.2010.91 · Cited by 76
DNRLMF-MDA:Predicting microRNA-Disease Associations Based on Similarities of microRNAs and Diseases
Yan, C., Wang, J., Ni, P., Lan, W., Wu, F., & Pan, Y. F. (2017) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2017.2776101 · Cited by 76
Ni, X., Xia, T., Zhao, Y., Zhou, W., Wu, N., Liu, X., Ding, Q., Zha, X., Sha, J., & Wang, S. (2013) · Cancer Science · doi:10.1111/cas.12309 · Cited by 76
miR-196 regulates axial patterning and pectoral appendage initiation
He, X., Yan, Y., Eberhart, J. K., Herpin, A., Wagner, T. U., Schartl, M., & Postlethwait, J. H. (2011) · Developmental Biology · doi:10.1016/j.ydbio.2011.07.014 · Cited by 76
Wu, Q., Guo, R., Lin, M. T., Zhou, B., & Wang, Y. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.03.026 · Cited by 78
Phenotypic and Molecular Characterization of MCF10DCIS and SUM Breast Cancer Cell Lines
Barnabas, N., & Cohen, D. (2013) · International Journal of Breast Cancer · doi:10.1155/2013/872743 · Cited by 79
Fils-Aimé, N., Dai, M., Guo, J., El-Mousawi, M., Kahramangil, B., Neel, J.-C., & Lebrun, J. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.430934 · Cited by 80
MicroRNAs -the Next Generation Therapeutic Targets in Human Diseases
Sakthivel, S., Selvan, S. T., Archunan, G., Gulyás, B. Z., & Padmanabhan, P. (2013) · Theranostics · doi:10.7150/thno.7026 · Cited by 76
Yoo, B., Kavishwar, A., Ross, A., Wang, P., Tabassum, D. P., Polyák, K., Barteneva, N., Petkova, V., Pantazopoulos, P., Tena, A., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0888 · Cited by 78
Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma
Kumar, D., Gorain, M., Kundu, G., & Kundu, G. C. (2017) · Molecular Cancer · doi:10.1186/s12943-016-0578-3 · Cited by 78
Grijalvo, S., Alagia, A., Jorge, A. F., & Eritja, R. (2018) · Genes · doi:10.3390/genes9020074 · Cited by 79
TWIST1 Overexpression is Associated with Nodal Invasion and Male Sex in Primary Colorectal Cancer
Valdés-Mora, F., Gómez del Pulgar, T., Bandrés, E., Cejas, P., Ramírez de Molina, A., Pérez-Palacios, R., Gallego-Ortega, D., García-Cabezas, M. A., Casado, E., Larrauri, J., et al. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0166-x · Cited by 75
MicroRNAs in pathogenesis of breast cancer: Implications in diagnosis and treatment
Shah, N. R. (2014) · World Journal of Clinical Oncology · doi:10.5306/wjco.v5.i2.48 · Cited by 76
Zhu, M., Yi, M., Kim, C. H., Deng, C., Li, Y., Medina, D., Stephens, R. M., & Green, J. E. (2011) · Genome biology · doi:10.1186/gb-2011-12-8-r77 · Cited by 75
A Key Role of microRNA-29b for the Suppression of Colon Cancer Cell Migration by American Ginseng
Poudyal, D., Cui, X., Le, P. M., Hofseth, A. B., Windust, A. J., Nagarkatti, M., Nagarkatti, P. S., Schetter, A. J., Harris, C. C., & Hofseth, L. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075034 · Cited by 74
Microenvironment-induced downregulation of miR-193b drives ovarian cancer metastasis
Mitra, A. K., Chiang, C. Y., Tiwari, P., Tomar, S., Watters, K. M., Peter, M. E., & Lengyel, E. R. (2015) · Oncogene · doi:10.1038/onc.2015.43 · Cited by 75
Novel clinical therapeutics targeting the epithelial to mesenchymal transition
Kothari, A. N., Mi, Z., Zapf, M. A. C., & Kuo, P. C. (2014) · Clinical and Translational Medicine · doi:10.1186/s40169-014-0035-0 · Cited by 74
Zaravinos, A., Bonavida, B., Chatzaki, Ε., & Baritaki, S. (2018) · Cancers · doi:10.3390/cancers10090287 · Cited by 75
Xiang, W., He, J., Huang, C., Chen, L., Tao, D., Wu, X., Wang, M., Luo, G., Xiao, X., Zeng, F., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.2926 · Cited by 77
Glycogen Synthase Kinase 3 Beta (GSK3β) Phosphorylates the RNAase III Enzyme Drosha at S300 and S302
Tang, X., Li, M., Tucker, L. D., & Ramratnam, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020391 · Cited by 74
Mh, Y., Lin, B.-R., Chang, C., Chen, S.-T., Lin, S.-K., Kuo, M. Y.-P., Jeng, Y., Kuo, M.-L., & Chang, C. (2011) · Oncogene · doi:10.1038/onc.2011.423 · Cited by 73
Epigenetic regulation of normal human mammary cell type–specific miRNAsPreprint
Vrba, L., Garbe, J. C., Stampfer, M. R., & Futscher, B. W. (2011) · Genome Research · doi:10.1101/gr.123935.111 · Cited by 76
Haque, I., Banerjee, S., Mehta, S., De, A., Majumder, M., Mayo, M. S., Kambhampati, S., Campbell, D. R., & Banerjee, S. K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.284158 · Cited by 74
MiR-23b targets cyclin G1 and suppresses ovarian cancer tumorigenesis and progression
Yan, J. Y., Jiang, J., Meng, X., Xiu, Y., & Zong, Z. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0307-1 · Cited by 73
The emerging role of miR-506 in cancer
Li, J., Ju, J., Ni, B., & Wang, H. (2016) · Oncotarget · doi:10.18632/oncotarget.11294 · Cited by 73
Metadata
- Authors
- Ma, L., Teruya-Feldstein, J., & Weinberg, R. A.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Corresponding author
- Weinberg, Robert A.
- Venue
- Nature
- Published
- 2007-09-26
- Volume
- 449
- Issue
- 7163
- Pages
- 682-688
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2047529648
- Cited by
- 2,605
- References
- 49
- Citations by year
- 2026: 34 · 2025: 36 · 2024: 66 · 2023: 69 · 2022: 75 · 2021: 120 · 2020: 106 · 2019: 123 · 2018: 113 · 2017: 151 · 2016: 160 · 2015: 196 · 2014: 215 · 2013: 226 · 2012: 220
- FWCI
- 60.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- microRNA-10b, breast cancer, metastasis, tumor invasion, cell migration, Twist transcription factor, HOXD10, RhoC, Hox genes, microRNA target regulation, clinical progression
- MeSH terms
- rhoC GTP-Binding Protein, Animals, Base Sequence, Breast Neoplasms, Cell Movement, Humans, Lung Neoplasms, Neoplasm Invasiveness, Neoplasm Metastasis, Peritoneal Neoplasms, Transcription Factors, Gene Expression Regulation, Neoplastic, Homeodomain Proteins, rho GTP-Binding Proteins, MicroRNAs, Cell Line, Tumor, Mice, Twist-Related Protein 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review